Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03897855
Other study ID # CH-NIORT-2018-02
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 1, 2019
Est. completion date March 26, 2021

Study information

Verified date July 2021
Source Centre Hospitalier de Niort
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In the elderly, we can see a post-traumatic syndrome associated with an event that occurred before old age that had not previously manifested or not fully manifested. This little-known pathology and notable psychiatric co-morbidities (depression, anxiety) can take in elderly subjects different masks that interfere with diagnosis and treatment. The data in the literature suggest that this Post-Traumatic Stress Disorder with Delayed Expression (TSPT-R) may be related to a deficiency of the executive functions of inhibition, and more particularly a deficit of mental memory inhibition and therefore the removal of unwanted memories.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date March 26, 2021
Est. primary completion date April 15, 2019
Accepts healthy volunteers No
Gender All
Age group 65 Years to 85 Years
Eligibility Inclusion Criteria: - Regarding the constitution of the group patient (TSPT-R): - Subjects 65 years of age or older - Clinical diagnosis of delayed-onset PTSD according to DSM-5 criteria after 65 years - The traumatic event must have taken place at the latest before 65 years - Affiliated person or beneficiary of a social security scheme. - Written consent before any examination required by research) Regarding the constitution of the control group: - Subjects 65 years of age or older - No diagnosis of PTSD (delayed or not) or history of PTSD (delayed or not) - Affiliated person or beneficiary of a social security scheme. - Written consent before any examination required by the research). Exclusion Criteria: - For both groups: - Acute or chronic cognitive impairment known - GRECO MMSE pathological score less than or equal to the pathological threshold weighted according to level of education and age, namely: - 22 if no diploma - 23 if certificate of study - 25 if patent - 26 if bin or more - Remove one point at each threshold if age> 80 years - Sensory or motor disorder preventing the passing of different tests - Psychotic disorder - Mood disorder in decompensation (for depression, HAD-D score equal to or greater than 11) - Disorder of the use of a moderate or severe substance (except tobacco). - Patients under guardianship or curatorship.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Post Traumatic Stress Disorder
The test "Think / No-Think"

Locations

Country Name City State
France Centre Hospitalier de Niort Niort

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier de Niort

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Inhibition score measured by the Think / No-Think Test the average of the inhibition score measured by the "Think / No-Think" test as defined by Anderson and Green (2001) and then reviewed by Anderson et al. in 2011 1 month